2137 Efficacy of Immunotherapy with Allergenic Extract of Aedes Aegypti in the Treatment of Large Local Reaction to Mosquito Bites in Children

Monday, 5 December 2011
Poster Hall (Cancún Center)

Maria Amelia Manrique, MD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Sandra González-Díaz, MD, PhD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Alfredo Arias-Cruz, MD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Marisela Hernandez, MD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Claudia Gallego, MD , Regional Center of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Diego Garcia-Calderin, MD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Karla Mejia, MD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Maricruz Calva, MD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Luis Dominguez, MD , Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, Mexico

Background: Allergic reactions to insects are a global problem. The objective of this study was to assess the efficacy of immunotherapy with allergenic extract of Aedes aegypti for the treatment of large local reactions (LLR) to mosquito bites in children.

Methods: Experimental, comparative, prospective, longitudinal and randomized none blinded study was conducted. We included 2 to 15 year old children with a history of large local reactions to mosquito bites. Sensitization was confirmed by a positive prick test. One group was treated with subcutaneous immunotherapy with extract of Aedes aegypti during 5 months and a second group received only antihistamine as needed. Diary symptoms and medication use were recorded in each case. The presence of adverse reactions to immunotherapy was also documented.

Results: A total of 35 patients from August 2009 to September 2010. Twenty-eight patients completed the study (16 male were included, with mean 7 ± 2.5 years) 15 in the immunotherapy group and 13 in the control group. The immunotherapy group showed a decrease in the diameter of the wheal and flare as well as the duration of the reaction and the use of drugs, from the third month of treatment, compared with the control group (p <0.001).

Conclusions: Our results suggest that immunotherapy with extract of Aedes aegypti, could modify the natural history of LLR to mosquito bites in children. Additional studies are needed to determine the optimal length treatment of the scheme and its long-term effects.

References

  1. Moffitt JE, Golden DB, Nicklas R. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol 2004; 114:869-867.
  2. Golden D, Kelly D, Hamilton R, Craig T. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 2009; 123:1371-5